NFE2L2 and neoplasm: Moreover, our study extends the information about the regulation of a wide variety of metabolic genes and pathways by NRF2 and highlights a strategy for the pharmacological inhibition of NRF2 and its associated gene signature in NSCLC to reduce tumor growth and drug resistance.